AI Article Synopsis

  • The study evaluated the effectiveness of oestradiol valerate/dienogest (E2V/DNG) for treating heavy or prolonged menstrual bleeding in women without underlying health issues, using data from two similar double-blind trials.
  • After six months, women taking E2V/DNG experienced an 88% reduction in menstrual blood loss compared to just 24% in those on placebo, with the most significant improvement noted after the first withdrawal bleed.
  • The findings concluded that E2V/DNG significantly outperformed placebo in reducing menstrual blood loss, and this effect started quickly and continued to improve over time.

Article Abstract

Objectives: To evaluate the efficacy of oestradiol valerate/dienogest (E2V/DNG) for the treatment of heavy and/or prolonged menstrual bleeding without organic pathology based on the analysis of data from two identically designed double-blind, randomised studies.

Methods: Women aged ≥ 18 years with heavy and/or prolonged menstrual bleeding were randomised to E2V/DNG (n = 269) or placebo (n = 152) for 196 days. Objective changes in menstrual blood loss (MBL) volume were assessed using the alkaline haematin method.

Results: After six months of treatment, median MBL decreased by 88% with E2V/DNG compared with 24% with placebo. The greatest reduction was achieved at the first withdrawal bleed after treatment initiation and it was sustained with no loss of effect throughout treatment.

Conclusion: E2V/DNG was more effective than placebo in reducing MBL in women with heavy and/or prolonged menstrual bleeding without organic pathology. The reduction was largely achieved as early as the first withdrawal bleed, with further gradual improvement throughout treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154543PMC
http://dx.doi.org/10.3109/13625187.2011.591456DOI Listing

Publication Analysis

Top Keywords

heavy and/or
16
and/or prolonged
16
prolonged menstrual
16
menstrual bleeding
16
bleeding organic
12
treatment heavy
8
organic pathology
8
reduction achieved
8
withdrawal bleed
8
menstrual
5

Similar Publications

Because a significant portion of oil remains in carbonate reservoirs, efficient techniques are essential to increase oil recovery from carbonate reservoirs. Wettability alteration is crucial for enhanced oil recovery (EOR) from oil-wet reservoirs. This study investigates the impact of different substances on the wettability of dolomite and calcite rocks.

View Article and Find Full Text PDF

Cadmium, a toxic heavy metal, poses significant global concern. A strain of the genus Pseudomonas, CD3, demonstrating significant cadmium resistance (up to 3 mM CdCl.HO) was identified from a pool of 26 cadmium-resistant bacteria isolated from cadmium-contaminated soil samples from Malda, India.

View Article and Find Full Text PDF

Strongly coordinating mediator enables single-step resource recovery from heavy metal-organic complexes in wastewater.

Nat Commun

December 2024

State Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China.

Heavy metals complexed with organic ligands are among the most critical carcinogens threatening global water safety. The challenge of efficiently and cost-effectively removing and recovering these metals has long eluded existing technologies. Here, we show a strategy of coordinating mediator-based electro-reduction (CMBER) for the single-step recovery of heavy metals from wastewater contaminated with heavy metal-organic complexes.

View Article and Find Full Text PDF

Catalytic upcycling of polyethylene terephthalate (PET) into high-value oxygenated products is a fascinating process, yet it remains challenging. Here, we present a one-step tandem strategy to realize the thermal catalytic oxidation upcycling of PET to terephthalic acid (TPA) and high-value glycolic acid (GA) instead of ethylene glycol (EG). By using the Au/NiO with rich oxygen vacancies as catalyst, we successfully accelerate the hydrolysis of PET, accompanied by obtaining 99% TPA yield and 87.

View Article and Find Full Text PDF

Owing to their attractive antitumor effects, aminated fullerene derivatives are emerging as promising therapeutic drugs for cancer. However, their in vivo applications are severely limited due to cation toxicity. To address this problem, human heavy chain ferritin (HFn), possessing natural biocompatibility is utilized, to develop a novel supramolecular assembly drug delivery system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!